OZONE: A new medical drug

336 Pages·2011·3.57 MB·English

by  Velio Bocci (auth.)

Ozone

Velio Bocci
Ozone
A New Medical Drug
Second Edition
1 3
VelioBocci
DepartmentofPhysiology
UniversityofSiena
viaA.Moro2
53100Siena
Italy
[email protected]
ISBN978-90-481-9233-5 e-ISBN978-90-481-9234-2
DOI10.1007/978-90-481-9234-2
SpringerDordrechtHeidelbergLondonNewYork
LibraryofCongressControlNumber:2010936097
©SpringerScience+BusinessMediaB.V.2005,2011
Nopartofthisworkmaybereproduced,storedinaretrievalsystem,ortransmittedinanyformorby
anymeans,electronic,mechanical,photocopying,microfilming,recordingorotherwise,withoutwritten
permissionfromthePublisher,withtheexceptionofanymaterialsuppliedspecificallyforthepurpose
ofbeingenteredandexecutedonacomputersystem,forexclusiveusebythepurchaserofthework.
Printedonacid-freepaper
SpringerispartofSpringerScience+BusinessMedia(www.springer.com)
Thisbookisdedicatedtoallpatientswith
thewishtoregaintheirhealthwithor
withoutoxygen-ozonetherapy

Foreword
In2002,Prof.Boccipublishedabookentitled“Oxygen-OzoneTherapy.ACritical
Evaluation” with ample scientific data based largely on his experiments indicat-
ing the usefulness and atoxicity of ozone therapy in some diseases. However the
book contained too many details and it was difficult to read for the busy physi-
cian and even more for the layman. He has now written a new version that is
shorter and concise. Nonetheless the mechanisms of action of ozone, which are
essential for understanding how ozone acts through a number of messengers, are
clearlyexplainedinascientificbutplainlanguage.Theclinicalparthasbeengreatly
extendedandincludesnewpathologiesaswellasdiseasespreviouslyconsideredbut
nowamplifiedwithnewdata.
The book is primarily intended for ozone-therapists, who want to refine tech-
niques,expandtreatmentmodalitiesandsolveproblems,butwillbeequallyuseful
for physicians interested in this approach. However it can also be read by the lay-
man, to provide further insight into this aspect of complementary medicine. The
bookgivesacompleteviewofthisapproachincludingpracticalaspectsofroutesof
administrationandthepossibilityofsimpleself-medication.
Againsttheprejudicethatozoneistoxic,theaccuratedescriptionofsideeffects
revealsthattheyareofminimalrelevanceanditisevenmoresurprisingthatozone
therapy yields a feeling of wellness in the majority of patients. This is a crucial
pointthathasbeenclearlyexplainedbydefiningthetherapeuticrangewithinwhich
ozoneisaveryusefuldrug.Itisinterestingtolearnthatozonecanslowlyinducean
increaseofantioxidantdefencesthatisauniquepropertymostimportantforcorrect-
ing the chronic oxidative stress plaguing atherosclerosis, diabetes, viral infections
andcancer.
Ihavebeenimpressedbytheenthusiasmforthistherapythatcomestolighton
readingthebook.Veliotoldmethathehassubmittedhimselfallpossiblemethods
ofozoneadministrationandhasalsoperformedmanyexperiments.Fromhisresults
andtheoftenincredibleimprovementsobservedinveryillpatients,hehasthefirm
convictionthatozonetherapyisnotaplacebo!Jokingly,healsoassuredmethathe
isthelivingproofofozonetherapyatoxicity.
Ozoneneverfinishessurprisingusbyitsversatilityrecentlyshownbydelivering
therapeuticactivityinOrthopaedicsandDentistry.IamconvincedthatVelio’swork
vii
viii Foreword
will dispel misconceptions and scepticism and it will be useful for years to come
bothtophysiciansandpatients,wholiketounderstandthemeaningofthetreatment.
Indeed this book represents the first comprehensive framework for understanding
andrecommendingozonetherapyinsomediseases.
London TheLordColwyn
August2004
Preface (Second Edition, 2010)
FiveyearshaveelapsedfromthefirstEditionpublishedin2005and,inthemean-
time, work from mine and other Laboratories and clinics has further clarified and
improvedtheuseofozonetherapy.However,inspiteofsomenewworkperformedin
ItalyandotherCountries,itisunfortunatethatimportantclinicalstudiesperformed
accordingtotheHelsinki’sparadigmhavenotyetbeenperformedorpublished.A
small exception is represented by a Cuban trial but their clinical investigation of
the diabetic foot by using only 20 days of rectal insufflation of ozone is too good
toberealisticanditneedstobeconfirmedbyafarmorereliableprocedureasthe
ozonated autohemotherapy. As far as I know, good journals do not accept papers
based on such imprecise procedure as the rectal insufflation of ozone. An exper-
imental work carried out in Germany on a experimental cancer model in rabbits
wasinterestingforexaminingtheintraperitonealroutebutasIpointedoutinalet-
ter to the Editor of the Int J Cancer, as it also has happened for other approaches,
experimental acute cancer in animals cannot be equated to the slow progressing
human cancers. But the worst publication was a clinical trial published in the
Lancet, January 2008 reporting the failure of a repeated administration of a small
(10 ml) volume of blood ozonated with as many as 75 mg ozone + UV treatment
and + heat-stress in patients. This publication show how an absolutely irrational
and irresponsible procedure called Celacade can seriously damage the ozonether-
apyconcept.AlthoughIwroteaseverecounter-pointtotheLancet,thedamagehas
notyetbeencorrectedbecauseinspiteofmyefforts,ithasnotyetbeenpossibleto
carryoutanappropriatetrialinchronicheartfailure.
Thus, where we are now? We know how ozone works, the precise therapeu-
tic window, its absolute safety newly established in recent papers and the very
likely advantages of ozonetherapy over current orthodox medicine in vascular
diseases and in the dry form of age-related macular degeneration. We are now
sure that ozonetherapy can represent a useful support in chronic infections and it
has been accepted in orthopaedics and dentistry. However prejudice and lack of
knowledge persist in official medicine and it will be impossible to eradicate them
unless we can provide extensive, controlled and randomized studies published in
peer-reviewed international journals. Nonetheless this new edition reports several
ix